Zhongyuan Xiehe Cell Genetic Engineering Co., Ltd., founded in 1995, is a listed company, a well-known investment in biological resource storage project brand, integrating cell storage, genetic testing and clinical reagent research and development, anti-aging and beauty cosmetics production as one of the comprehensive enterprises
Zhongyuan Xiehe Cell Genetic Engineering Co., Ltd. (hereinafter referred to as "Zhongyuan Xiehe") is one of the earliest enterprises in China to invest in biological resource storage projects, and is also the only life science and technology enterprise (stock code 600645 driven by the dual core of "cell + gene" in Shanghai and Shenzhen in China. The company has advanced cell technology and a large cell resource storage network in China, and the cell storage volume has exceeded 300,000 copies.
The company adheres to the core strategy of "cell + gene" dual-core development, and its main business includes: neonatal stem cell storage business; neonatal adult genetic testing, advanced gene sequencing equipment development, biochemical reagent R&D and production and clinical testing business; adult cell storage business such as immune cell storage, fat cell storage, and tooth-derived stem cell storage; anti-aging and beauty cosmetics business featuring cell and gene technology; With the new model of "Internet + big health", it integrates online and offline sales and service promotion of life bank cards and other businesses.
After 17 years of operation, Zhongyuan Xiehe has developed into a leading life science and technology industry group in China. The company has a number of well-known domestic subsidiaries such as Xiehe Stem Cell Genetic Engineering Co., Ltd., Shanghai Zhicheng Biotechnology Co., Ltd., Heze Biotechnology Co., Ltd., Tianjin Heze Stem Cell Technology Co., Ltd., Zhongyuan Xiehe Gene Technology Co., Ltd., and has established two overseas subsidiaries in the United States, such as Zhongyuan Xiehe (USA) Co., Ltd. and Zhongyuan Xiehe (USA) Biotechnology Transformation Center, which has vigorously opened the pace of global layout.
Through the strategic layout of cell storage, genetic testing, biotherapy technology, pharmaceuticals, life big data, etc., Zhongyuan Xiehe is building a cutting-edge, inclusive and innovative "precision medicine" platform, bringing the freshest technology, the most first-class talents, and the most potential companies and projects to this open and inclusive platform, and promoting cutting-edge scientific and technological achievements to serve the health of the public as soon as possible.
Future prospects
As a listed company in the life science and technology industry, Zhongyuan Xiehe has always actively assumed social responsibility while focusing on the development of the enterprise itself, taking it as its own responsibility to improve the quality of life of all mankind, constantly strengthening and expanding the national industrial brand, and ranking among the world's biotechnology frontiers.
